MET and breast cancer: The hepatocyte growth factor receptor (MET) was among the top significant genes positively correlating with TGFBR2 expression (Fig. 2A and Table S3), which could be validated using an independent dataset of breast cancer cell lines (Fig. S3A) (Kao et al., 2009).